Want to join the conversation?
$OREX 2Q15 Call: In partnership with Takeda, resolved all outstanding disputes between the companies. Reached agreement and finalized and amended a restated collaboration agreement. In terms of US performance, Contrave has quickly established itself as the most prescribed branded weight loss medication.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.